Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

ERG expression in intraductal carcinoma of the prostate: comparison with adjacent invasive prostatic adenocarcinoma.

Schneider TM, Osunkoya AO.

Mod Pathol. 2014 Aug;27(8):1174-8. doi: 10.1038/modpathol.2013.248. Epub 2014 Jan 10.

2.

Molecular evidence that invasive adenocarcinoma can mimic prostatic intraepithelial neoplasia (PIN) and intraductal carcinoma through retrograde glandular colonization.

Haffner MC, Weier C, Xu MM, Vaghasia A, Gürel B, Gümüşkaya B, Esopi DM, Fedor H, Tan HL, Kulac I, Hicks J, Isaacs WB, Lotan TL, Nelson WG, Yegnasubramanian S, De Marzo AM.

J Pathol. 2016 Jan;238(1):31-41. doi: 10.1002/path.4628. Epub 2015 Oct 14.

3.

Utility of PTEN and ERG immunostaining for distinguishing high-grade PIN from intraductal carcinoma of the prostate on needle biopsy.

Morais CL, Han JS, Gordetsky J, Nagar MS, Anderson AE, Lee S, Hicks JL, Zhou M, Magi-Galluzzi C, Shah RB, Epstein JI, De Marzo AM, Lotan TL.

Am J Surg Pathol. 2015 Feb;39(2):169-78. doi: 10.1097/PAS.0000000000000348.

4.

Foamy gland carcinoma of the prostate in needle biopsy: incidence, Gleason grade, and comparative α-methylacyl-CoA racemase vs. ERG expression.

Warrick JI, Humphrey PA.

Am J Surg Pathol. 2013 Nov;37(11):1709-14. doi: 10.1097/PAS.0b013e318293d85b.

PMID:
23797726
5.

[Diagnostic value of estimation of ERG expression in prostate adenocarcinoma and high-grade prostatic intraepithelial neoplasia].

Allina DO, Kekeeva TV, Moskvina LV, Shikeeva AA, Andreeva YY, Zavalishina LE, Frank GA.

Arkh Patol. 2015 Sep-Oct;77(5):36-42. doi: 10.17116/patol201577536-42. Russian.

PMID:
26978019
6.

ERG expression in mucinous prostatic adenocarcinoma and prostatic adenocarcinoma with mucinous features: comparison with conventional prostatic adenocarcinoma.

Johnson H, Zhou M, Osunkoya AO.

Hum Pathol. 2013 Oct;44(10):2241-6. doi: 10.1016/j.humpath.2013.05.006. Epub 2013 Jul 10.

PMID:
23849895
7.

Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue.

Andrews C, Humphrey PA.

Am J Surg Pathol. 2014 Jul;38(7):1007-12. doi: 10.1097/PAS.0000000000000205.

PMID:
24705308
8.

The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.

Yaskiv O, Zhang X, Simmerman K, Daly T, He H, Falzarano S, Chen L, Magi-Galluzzi C, Zhou M.

Am J Surg Pathol. 2011 Jul;35(7):1062-8. doi: 10.1097/PAS.0b013e318215cc03.

PMID:
21623182
9.

ERG positive prostatic cancer may show a more angiogenetic phenotype.

Strzępek A, Kaczmarczyk K, Białas M, Szpor J, Dyduch G, Szopiński T, Chłosta P, Okoń K.

Pathol Res Pract. 2014 Dec;210(12):897-900. doi: 10.1016/j.prp.2014.07.009. Epub 2014 Aug 9.

PMID:
25220615
10.

Immunohistochemical expression of Ets-related gene-transcriptional factor in adenocarcinoma prostate and its correlation with Gleason score.

Mannan R, Bhasin TS, Manjari M, Singh G, Bhatia PK, Sharma S.

Indian J Pathol Microbiol. 2016 Oct-Dec;59(4):489-495. doi: 10.4103/0377-4929.191794.

11.

ERG and PTEN status of isolated high-grade PIN occurring in cystoprostatectomy specimens without invasive prostatic adenocarcinoma.

Morais CL, Guedes LB, Hicks J, Baras AS, De Marzo AM, Lotan TL.

Hum Pathol. 2016 Sep;55:117-25. doi: 10.1016/j.humpath.2016.04.017. Epub 2016 May 14.

12.

The diagnostic utility of novel immunohistochemical marker ERG in the workup of prostate biopsies with "atypical glands suspicious for cancer".

He H, Magi-Galluzzi C, Li J, Carver P, Falzarano S, Smith K, Rubin MA, Zhou M.

Am J Surg Pathol. 2011 Apr;35(4):608-14. doi: 10.1097/PAS.0b013e31820bcd2d.

PMID:
21383613
13.

Frequent TMPRSS2-ERG rearrangement in prostatic small cell carcinoma detected by fluorescence in situ hybridization: the superiority of fluorescence in situ hybridization over ERG immunohistochemistry.

Schelling LA, Williamson SR, Zhang S, Yao JL, Wang M, Huang J, Montironi R, Lopez-Beltran A, Emerson RE, Idrees MT, Osunkoya AO, Man YG, Maclennan GT, Baldridge LA, Compérat E, Cheng L.

Hum Pathol. 2013 Oct;44(10):2227-33. doi: 10.1016/j.humpath.2013.05.005. Epub 2013 Jul 12.

PMID:
23850495
14.

Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.

He H, Osunkoya AO, Carver P, Falzarano S, Klein E, Magi-Galluzzi C, Zhou M.

BJU Int. 2012 Dec;110(11 Pt B):E751-5. doi: 10.1111/j.1464-410X.2012.11557.x. Epub 2012 Oct 9.

15.

ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma.

Miettinen M, Wang ZF, Paetau A, Tan SH, Dobi A, Srivastava S, Sesterhenn I.

Am J Surg Pathol. 2011 Mar;35(3):432-41. doi: 10.1097/PAS.0b013e318206b67b.

PMID:
21317715
16.

Cytoplasmic PTEN protein loss distinguishes intraductal carcinoma of the prostate from high-grade prostatic intraepithelial neoplasia.

Lotan TL, Gumuskaya B, Rahimi H, Hicks JL, Iwata T, Robinson BD, Epstein JI, De Marzo AM.

Mod Pathol. 2013 Apr;26(4):587-603. doi: 10.1038/modpathol.2012.201. Epub 2012 Dec 7.

17.

Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry.

Fontugne J, Davis K, Palanisamy N, Udager A, Mehra R, McDaniel AS, Siddiqui J, Rubin MA, Mosquera JM, Tomlins SA.

Mod Pathol. 2016 Feb;29(2):157-65. doi: 10.1038/modpathol.2015.148. Epub 2016 Jan 8.

18.

ERG protein expression in human tumors detected with a rabbit monoclonal antibody.

Yaskiv O, Rubin BP, He H, Falzarano S, Magi-Galluzzi C, Zhou M.

Am J Clin Pathol. 2012 Dec;138(6):803-10. doi: 10.1309/AJCP3K5VUFALZTKC.

PMID:
23161713
19.

Atypical Intraductal Cribriform Proliferations of the Prostate Exhibit Similar Molecular and Clinicopathologic Characteristics as Intraductal Carcinoma of the Prostate.

Hickman RA, Yu H, Li J, Kong M, Shah RB, Zhou M, Melamed J, Deng FM.

Am J Surg Pathol. 2017 Apr;41(4):550-556. doi: 10.1097/PAS.0000000000000794.

PMID:
28009609
20.

Small cell-like change in prostatic intraepithelial neoplasia, intraductal carcinoma, and invasive prostatic carcinoma: a study of 7 cases.

Lee S, Han JS, Chang A, Ross HM, Montironi R, Yorukoglu K, Lane Z, Epstein JI.

Hum Pathol. 2013 Mar;44(3):427-31. doi: 10.1016/j.humpath.2012.06.008. Epub 2012 Sep 29.

PMID:
23026197

Supplemental Content

Support Center